Moreover, RMPs, which displayed CD235 positivity, and EMPs (positive for CD62E) were detected in larger amounts (p < 0.001 for both) in ET patients who did not receive treatment versus treated patients and controls. The gene discussed is SELE; the disease is essential thrombocythemia.